Aspirin and Dipyridamole NDC 16714-964

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-964Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0964Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16714-964-01	16714096401	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-964-01)Marketed from Apr 3, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aspirin and Dipyridamole
Generic name (nonproprietary): aspirin and dipyridamole
Active ingredients: Aspirin — 25 mg/1Dipyridamole — 200 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: NorthStar Rx LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209048
Marketing start: Apr 3, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)
Identifiers: Product ID 16714-964_7e2fb079-3302-fd35-dab4-1991e997daecSPL ID 7e2fb079-3302-fd35-dab4-1991e997daecSPL set ID 465bbdac-a483-689a-811f-32923ea99fa7RxCUI 259081UNII R16CO5Y76E, 64ALC7F90CUPC 0316714964010
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714096401 followed by a unit qualifier and the quantity

Package 16714-0964-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 26, 2023.

Indications (excerpt from the label)

Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209048

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209048
Product	Strength	Form · route	Labeler	Product NDC
Aspirin and Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	Capsule, Extended releaseOral	Dr. Reddy's Laboratories Inc	43598-339